MARKET

HEPA

HEPA

Hepion Pharmaceuticals Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.620
+0.010
+0.62%
Opening 15:37 04/08 EDT
OPEN
1.580
PREV CLOSE
1.610
HIGH
1.680
LOW
1.565
VOLUME
328.84K
TURNOVER
--
52 WEEK HIGH
20.02
52 WEEK LOW
1.000
MARKET CAP
9.84M
P/E (TTM)
-0.0694
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average HEPA stock price target is 10.50 with a high estimate of 12.00 and a low estimate of 9.00.

EPS

HEPA News

More
  • BMY, TLRY among premarket gainers
  • Seeking Alpha - Article · 03/23 13:21
  • Coronavirus Pandemic Requires Patient Investing And A Focused Portfolio
  • Seeking Alpha - Article · 03/20 21:30
  • PENN, PSXP, APRN and AHT among midday movers
  • Seeking Alpha - Article · 03/20 16:43
  • Hepion Pharmaceuticals' CRV431 Demonstrates Efficacy in Human Idiopathic Pulmonary Fibrosis Translational Research Study
  • ACCESSWIRE · 03/12 13:15

Industry

Biotechnology & Medical Research
+2.97%
Pharmaceuticals & Medical Research
+2.82%

Hot Stocks

Symbol
Price
%Change

About HEPA

Hepion Pharmaceuticals Inc., formerly ContraVir Pharmaceuticals, Inc., is a clinical stage biopharmaceutical company. The Company is focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection. Its lead oral drug candidate, CRV431, reduces liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH. CRV431 is also being developed for viral hepatitis-induced liver disease. CRV431 targets multiple biochemical pathways involved in the progression of liver disease.
More

Webull offers kinds of Hepion Pharmaceuticals Inc stock information, including NASDAQ:HEPA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HEPA stock news, and many more online research tools to help you make informed decisions.